MedPage Today on MSN
Novel Biologic Gets Narrow Win for Preventing COPD Flare-ups
The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...
Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...
Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...
Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...
China: Severe emphysema, quantitatively assessed using high-resolution computed tomography (HRCT), is a strong independent ...
A multipronged exercise rehabilitation approach can improve function and quality of life in patients with severe respiratory impairment.
Researchers have indicated in a new study that a COPD Assessment Test-based definition of chronic bronchitis (CAT-CB) is more ...
Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...
Patients with COPD or interstitial lung disease who partook in a weekly online group singing program reported improved ...
Please provide your email address to receive an email when new articles are posted on . A cough score was used to determine severity and featured questions from three validated assessments. Poorer ...
Patients with both chronic obstructive pulmonary disease (COPD) and severe pain are at an almost 40% predicted probability of falling, indicating the potential interaction between the conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results